দেশ: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
ESTRADIOL HEMIHYDRATE, NORETHISTERONE ACETATE
B & S Healthcare
G03FA01
ESTRADIOL HEMIHYDRATE, NORETHISTERONE ACETATE
1/0.5 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
Progestogens and estrogens, sequential preparations
Authorised
2006-09-29
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Activelle 1mg/0.5mg Film-Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains anhydrous estradiol 1 mg (as estradiol hemihydrate) and norethisterone acetate 0.5 mg Excipients: Contains lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet _Product imported from Italy._ White, circular tablets, embossed with the Novo Nordisk bull symbol on one side ‘NOVO 288’ on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women with more than 1 year since last menses. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of or contraindicated for other medicinal products approved for the prevention of osteoporosis. The experience treating women older than 65 years is limited. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Activelle is a continuous combined hormone replacement product intended for use in women with an intact uterus. One tablet should be taken orally once a day without interruption, preferably at the same time every day. For initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also section 4.4) should be used. A switch to a higher dose combination product could be indicated if the response after 3 months is insufficient for satisfactory symptom relief. In women with amenorrhea and not taking HRT or women transferring from another continuous combined HRT product, treatment with Activelle may be started on any convenient day. In women transferring from sequential HRT regimens, treatment should start right a সম্পূর্ণ নথি পড়ুন